{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:58:50Z","timestamp":1790366330805,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00520-026-11098-8","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T01:08:22Z","timestamp":1786756102000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factors influencing acupuncture regimen completion by breast cancer patients: real-world data from an NCI-designated comprehensive cancer center"],"prefix":"10.1007","volume":"34","author":[{"given":"Maria Grosso","family":"Zelaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshelle","family":"Borjigin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Lahiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bausum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarite","family":"Melikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almira","family":"Catic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Mumford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Slomik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dattatraya","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Suk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetria","family":"Smith-Graziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Kalinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viraj A.","family":"Master","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,15]]},"reference":[{"issue":"1","key":"11098_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A (2025) Cancer statistics, 2025. CA Cancer J Clin 75(1):10\u201345","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"11098_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jpainsymman.2017.08.008","volume":"55","author":"CW Sullivan","year":"2018","unstructured":"Sullivan CW, Leutwyler H, Dunn LB et al (2018) Stability of symptom clusters in patients with breast cancer receiving chemotherapy. J Pain Symptom Manage 55(1):39\u201355","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"11098_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4048\/jbc.2018.21.1.37","volume":"21","author":"TK Yoo","year":"2018","unstructured":"Yoo TK, Jang MJ, Lee E, Moon HG, Noh DY, Han W (2018) Endocrine treatment-related symptoms and patient outcomes in breast cancer: a meta-analysis. J Breast Cancer 21(1):37\u201344","journal-title":"J Breast Cancer"},{"issue":"103865","key":"11098_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2024.103865","volume":"79","author":"MJ Heins","year":"2025","unstructured":"Heins MJ, de Ligt KM, Verloop J et al (2025) Adverse health effects after breast cancer up to 14 years after diagnosis. Breast 79(103865):103865","journal-title":"Breast"},{"key":"11098_CR5","doi-asserted-by":"crossref","unstructured":"Heins MJ, de Ligt KM, Verloop J, Siesling S, Korevaar JC, PSCCR group (2022) Adverse health effects after breast cancer up to 14 years after diagnosis. Breast 61:22\u201328","DOI":"10.1016\/j.breast.2021.12.001"},{"issue":"3","key":"11098_CR6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.5152\/tjbh.2016.3041","volume":"12","author":"F \u0130zci","year":"2016","unstructured":"\u0130zci F, \u0130lg\u00fcn AS, F\u0131nd\u0131kl\u0131 E, \u00d6zmen V (2016) Psychiatric symptoms and psychosocial problems in patients with breast cancer. J Breast Health 12(3):94\u2013101","journal-title":"J Breast Health"},{"issue":"11","key":"11098_CR7","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1089\/acm.2021.0102","volume":"27","author":"K Desai","year":"2021","unstructured":"Desai K, Liou K, Liang K, Seluzicki C, Mao JJ (2021) Availability of integrative medicine therapies at National Cancer Institute-designated comprehensive cancer centers and community hospitals. J Altern Complement Med 27(11):1011\u20131013","journal-title":"J Altern Complement Med"},{"issue":"6","key":"11098_CR8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s00520-024-08529-9","volume":"32","author":"KK Kwon","year":"2024","unstructured":"Kwon KK, Lacey J, Kerin-Ayres K, Heller G, Grant S (2024) Acupuncture for the treatment of the pain-fatigue-sleep disturbance-numbness\/tingling symptom cluster in breast cancer survivors: a feasibility trial. Support Care Cancer 32(6):332","journal-title":"Support Care Cancer"},{"issue":"12","key":"11098_CR9","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1089\/acm.2021.0133","volume":"27","author":"H Li","year":"2021","unstructured":"Li H, Schlaeger JM, Jang MK et al (2021) Acupuncture improves multiple treatment-related symptoms in breast cancer survivors: a systematic review and meta-analysis. J Altern Complement Med 27(12):1084\u20131097","journal-title":"J Altern Complement Med"},{"issue":"25","key":"11098_CR10","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1200\/JCO.2018.79.2721","volume":"36","author":"GH Lyman","year":"2018","unstructured":"Lyman GH, Greenlee H, Bohlke K et al (2018) Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO clinical practice guideline. J Clin Oncol 36(25):2647\u20132655","journal-title":"J Clin Oncol"},{"issue":"4","key":"11098_CR11","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1634\/theoncologist.2019-0489","volume":"25","author":"W Lu","year":"2020","unstructured":"Lu W, Giobbie-Hurder A, Freedman RA et al (2020) Acupuncture for chemotherapy-induced peripheral neuropathy in breast cancer survivors: a randomized controlled pilot trial. Oncologist 25(4):310\u2013318","journal-title":"Oncologist"},{"issue":"36","key":"11098_CR12","doi-asserted-by":"publisher","first-page":"4470","DOI":"10.1200\/JCO.2012.41.6222","volume":"30","author":"A Molassiotis","year":"2012","unstructured":"Molassiotis A, Bardy J, Finnegan-John J et al (2012) Acupuncture for cancer-related fatigue in patients with breast cancer: a pragmatic randomized controlled trial. J Clin Oncol 30(36):4470\u20134476","journal-title":"J Clin Oncol"},{"issue":"3","key":"11098_CR13","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1177\/1534735418754309","volume":"17","author":"T Bao","year":"2018","unstructured":"Bao T, Li Q, DeRito JL, Seluzicki C, Im EO, Mao J (2018) Barriers to acupuncture use among breast cancer survivors: a cross-sectional analysis. Integr Cancer Ther 17(3):854\u2013859","journal-title":"Integr Cancer Ther"},{"key":"11098_CR14","doi-asserted-by":"publisher","DOI":"10.1177\/15347354221077277","volume":"21","author":"Y Widgren","year":"2022","unstructured":"Widgren Y, Fransson P, Efverman A (2022) Acupuncture in patients undergoing cancer therapy: their interest and belief in acupuncture is high, but few are using it. Integr Cancer Ther 21:15347354221077277","journal-title":"Integr Cancer Ther"},{"issue":"5","key":"11098_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jval.2019.02.004","volume":"22","author":"D Cella","year":"2019","unstructured":"Cella D, Choi SW, Condon DM et al (2019) PROMIS\u00ae adult health profiles: efficient short-form measures of seven health domains. Value Health 22(5):537\u2013544","journal-title":"Value Health"},{"issue":"7","key":"11098_CR16","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s11136-018-1842-3","volume":"27","author":"RD Hays","year":"2018","unstructured":"Hays RD, Spritzer KL, Schalet BD, Cella D (2018) PROMIS\u00ae-29 v2.0 profile physical and mental health summary scores. Qual Life Res 27(7):1885\u20131891","journal-title":"Qual Life Res"},{"issue":"11","key":"11098_CR17","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","volume":"63","author":"D Cella","year":"2005","unstructured":"Cella D, Riley W, Stone A et al (2005) The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol 63(11):1179\u20131194","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"11098_CR18","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1007\/s11136-015-1010-y","volume":"24","author":"KE Flynn","year":"2015","unstructured":"Flynn KE, Dew MA, Lin L et al (2015) Reliability and construct validity of PROMIS\u00ae measures for patients with heart failure who undergo heart transplant. Qual Life Res 24(11):2591\u20132599","journal-title":"Qual Life Res"},{"issue":"2","key":"11098_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/cncr.30354","volume":"123","author":"RE Jensen","year":"2017","unstructured":"Jensen RE, Moinpour CM, Potosky AL et al (2017) Responsiveness of 8 Patient-Reported Outcomes Measurement Information System (PROMIS) measures in a large, community-based cancer study cohort. Cancer 123(2):327\u2013335","journal-title":"Cancer"},{"issue":"12","key":"11098_CR20","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1007\/s11136-019-02261-2","volume":"28","author":"NE Rothrock","year":"2019","unstructured":"Rothrock NE, Cook KF, O\u2019Connor M, Cella D, Smith AW, Yount SE (2019) Establishing clinically-relevant terms and severity thresholds for Patient-Reported Outcomes Measurement Information System\u00ae (PROMIS\u00ae) measures of physical function, cognitive function, and sleep disturbance in people with cancer using standard setting. Qual Life Res 28(12):3355\u20133362","journal-title":"Qual Life Res"},{"key":"11098_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16213678","author":"G Palmateer","year":"2024","unstructured":"Palmateer G, Nicaise EH, Goodstein T et al (2024) Paraneoplastic resolution holds prognostic utility in patients with metastatic renal cell carcinoma. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers16213678","journal-title":"Cancers (Basel)"},{"issue":"1","key":"11098_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/1534735416660384","volume":"16","author":"PL Judson","year":"2017","unstructured":"Judson PL, Abdallah R, Xiong Y, Ebbert J, Lancaster JM (2017) Complementary and alternative medicine use in individuals presenting for care at a Comprehensive Cancer Center. Integr Cancer Ther 16(1):96\u2013103","journal-title":"Integr Cancer Ther"},{"issue":"10","key":"11098_CR23","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1093\/pm\/pnz087","volume":"20","author":"KT Liou","year":"2019","unstructured":"Liou KT, Hung TKW, Meghani SH et al (2019) What if acupuncture were covered by insurance for pain management? A cross-sectional study of cancer patients at one academic center and 11 community hospitals. Pain Med 20(10):2060\u20132068","journal-title":"Pain Med"},{"issue":"1","key":"11098_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6882-14-7","volume":"14","author":"JJ Mao","year":"2014","unstructured":"Mao JJ, Tan T, Li SQ, Meghani SH, Glanz K, Bruner D (2014) Attitudes and barriers towards participation in an acupuncture trial among breast cancer patients: a survey study. BMC Complement Altern Med 14(1):7","journal-title":"BMC Complement Altern Med"},{"issue":"2","key":"11098_CR25","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1177\/1534735409360666","volume":"9","author":"E Dean-Clower","year":"2010","unstructured":"Dean-Clower E, Doherty-Gilman AM, Keshaviah A et al (2010) Acupuncture as palliative therapy for physical symptoms and quality of life for advanced cancer patients. Integr Cancer Ther 9(2):158\u2013167","journal-title":"Integr Cancer Ther"},{"key":"11098_CR26","doi-asserted-by":"crossref","unstructured":"Epstein AS, Liou KT, Romero S (2023) Acupuncture vs massage for pain in patients living with advanced cancer: The IMPACT randomized clinical trial: the IMPACT randomized clinical trial. JAMA Netw Open 6(11)","DOI":"10.1001\/jamanetworkopen.2023.42482"},{"issue":"2","key":"11098_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/jama.2018.8907","volume":"320","author":"DL Hershman","year":"2018","unstructured":"Hershman DL, Unger JM, Greenlee H et al (2018) Effect of acupuncture vs sham acupuncture or waitlist control on joint pain related to aromatase inhibitors among women with early-stage breast cancer: a randomized clinical trial. JAMA 320(2):167\u2013176","journal-title":"JAMA"},{"issue":"3","key":"11098_CR28","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1188\/14.ONF.274-285","volume":"41","author":"CM Bender","year":"2014","unstructured":"Bender CM, Gentry AL, Brufsky AM et al (2014) Influence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancer. Oncol Nurs Forum 41(3):274\u2013285","journal-title":"Oncol Nurs Forum"},{"issue":"1","key":"11098_CR29","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1186\/s12913-020-05753-x","volume":"20","author":"I Ricci-Cabello","year":"2020","unstructured":"Ricci-Cabello I, V\u00e1squez-Mej\u00eda A, Canelo-Aybar C et al (2020) Adherence to breast cancer guidelines is associated with better survival outcomes: a systematic review and meta-analysis of observational studies in EU countries. BMC Health Serv Res 20(1):920","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"11098_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10549-020-05920-y","volume":"185","author":"M Yusufov","year":"2021","unstructured":"Yusufov M, Nathan M, Wiley A, Russell J, Partridge A, Joffe H (2021) Predictors of increased risk for early treatment non-adherence to oral anti-estrogen therapies in early-stage breast cancer patients. Breast Cancer Res Treat 185(1):53\u201362","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"11098_CR31","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1158\/1940-6207.CAPR-11-0172","volume":"4","author":"SR Land","year":"2011","unstructured":"Land SR, Cronin WM, Wickerham DL et al (2011) Cigarette smoking, obesity, physical activity, and alcohol use as predictors of chemoprevention adherence in the National Surgical Adjuvant Breast and Bowel Project P-1 Breast Cancer Prevention Trial. Cancer Prev Res (Phila) 4(9):1393\u20131400","journal-title":"Cancer Prev Res (Phila)"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11098-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11098-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11098-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:02:30Z","timestamp":1790362950000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-11098-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,15]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["11098"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11098-8","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,15]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KK: Consulting: Genentech\/Roche, Gilead, Seattle Genetics, AstraZeneca, Daiichi Sankyo, Puma Biotechnology, Mersana, Menarini Silicon Biosystems, Myovant Sciences, Merck, Eli Lilly, Pfizer, Novartis, Mersana, ProteinQure, bioTheranostics, Regor, Relay Therapeutics. Employee: ADC Therapeutics (Spouse).","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"855"}}